APA (7th ed.) Citation

Lee, M. M., Lernia, V. D., Peccerillo, F., Bardazzi, F., Tabanelli, M., Ricci, M., . . . Conti, A. (2025). Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: Real-life experience from Emilia-Romagna centers, Italy. PAGEPress Publications.

Chicago Style (17th ed.) Citation

Lee, Marco May, et al. Efficacy and Safety of Adalimumab Biosimilar GP2017 in a 24-month Treatment Period for Plaque Psoriasis: Real-life Experience from Emilia-Romagna Centers, Italy. PAGEPress Publications, 2025.

MLA (9th ed.) Citation

Lee, Marco May, et al. Efficacy and Safety of Adalimumab Biosimilar GP2017 in a 24-month Treatment Period for Plaque Psoriasis: Real-life Experience from Emilia-Romagna Centers, Italy. PAGEPress Publications, 2025.